Literature DB >> 7861906

Mutation in coagulation factor V associated with resistance to activated protein C in patients with coronary artery disease.

W März, H Seydewitz, B Winkelmann, M Chen, M Nauck, I Witt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7861906

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Myocardial infarction in patients with normal coronary arteries: proposed pathogenesis and predisposing risk factors.

Authors:  S P Pinney; L E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  Incidence of factor V Leiden in patients with acute myocardial infarction.

Authors:  M S Gowda; M L Zucker; J L Vacek; W L Carriger; D L Van Laeys; J M Rachel; B D Strope
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

3.  Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.

Authors:  N Irani-Hakime; H Tamim; G Elias; S Choueiry; R Kreidy; J L Daccache; W Y Almawi
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

4.  Evidence against heterozygous coagulation factor V 1691 G-->A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction.

Authors:  W Prohaska; H Mannebach; M Schmidt; U Gleichmann; K Kleesiek
Journal:  J Mol Med (Berl)       Date:  1995-10       Impact factor: 4.599

5.  Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries.

Authors:  A Dacosta; B Tardy-Poncet; K Isaaz; A Cerisier; P Mismetti; S Simitsidis; J Reynaud; B Tardy; M Piot; H Decousus; D Guyotat
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

6.  Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm.

Authors:  Katarzyna Oszajca; Konrad Wroński; Grażyna Janiszewska; Małgorzata Bieńkiewicz; Michał Panek; Jacek Bartkowiak; Janusz Szemraj
Journal:  Exp Ther Med       Date:  2012-06-12       Impact factor: 2.447

7.  Factor VLeiden and prothrombin G20210A gene polymorphisms in patients with coronary artery disease.

Authors:  Bahadir Ercan; Lülüfer Tamer; Nehir Sucu; Hasan Pekdemir; Ahmet Camsari; Uğur Atik
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.